We have just launched a $500,000 fundraising campaign in order to begin a clinical trial. During the clinical trial, one-year of Ketamine infusion treatments will be provided free-of-charge to eligible veterans suffering from PTSD.
Our goal is to make ketamine treatment affordable for veterans suffering from PTSD. Ketamine’s ability to dramatically reduce PTSD symptoms have been proven, but the effects do not always last a long time, requiring numerous maintenance infusions sometimes as many as one infusion every two weeks. Unfortunately, insurance companies do not cover ketamine infusions and can end up costing veterans between $5,000 and $10,000 annually to be treated. CureALL Research Foundation is working with Arizona Ketamine Treatment and Research Institute (AKTARI) to develop new treatment protocols and research ways for ketamine to have a longer lasting effect. Reduction in patient cost will result from reducing the number of ketamine infusions for the same or better results. To help further reduce costs, in association with other research institutions and medical facilities, we will compile data to show insurance companies that there are real and sustainable benefits to ketamine infusion therapy for patients suffering from PTSD. Reduction in patient cost will result from infusions becoming a covered benefit by Medicare, AHCCCS, VA, and commercial health insurance plans. Insurance companies need to know that this is worth covering and in many cases will reduce patient’s dependence on other expensive medications. We are here to help people that don’t have options! Ketamine infusions should not be priced out of reach for the general population and with your help, we can improve thousands of veterans’ lives! #VeteransPTSD @cureallresearch @arizonaketamine
0 Comments
|
CureAll BlogArchivesCategories
|